Scientists Uncover a Hidden Mechanism That Helps the Brain Stay in Balance
Researchers at the University of Miami Miller School of Medicine mapped how ELFN proteins connect with glutamate receptors to regulate communication between neurons, providing new insight into brain homeostasis and possible directions for future drug discovery.
Key Takeaways
- University of Miami Miller School of Medicine researchers mapped how ELFN proteins connect with group III metabotropic glutamate receptors to help regulate communication between neurons.
- The study identified a previously unknown receptor-binding pocket and evidence of a feedback mechanism that may help synapses fine-tune signaling strength.
- The work provides a structural foundation for future drug-discovery research.
The human brain is constantly adjusting.
A strong smell fades after a few minutes. Bright sunlight becomes easier to tolerate. Sounds that first grab our attention gradually blend into the background. Behind each of these experiences is the brain’s remarkable ability to maintain balance, ensuring that signals remain strong enough to detect but not so overwhelming that they drown out everything else.
Scientists call this process homeostasis.
“One of the open, big questions in neuroscience is how the brain maintains its homeostasis,” said Kirill Martemyanov, Ph.D., professor and chair of physiology and biophysics at the University of Miami Miller School of Medicine. “How does it balance it so that the signals are never too strong to saturate it, but also not too weak to lose them.”
A published study in Science Advances provides the clearest picture yet of one molecular system that helps make that balance possible. The research reveals, for the first time, exactly how two proteins help regulate communication between neurons, a discovery that could help scientists better understand neurological disorders and eventually identify new therapeutic targets.
How Does the Brain Keep Its Signals in Balance?
The study focused on a family of proteins involved in regulating communication between neurons.
Brain cells communicate through junctions called synapses, where chemical messengers carry signals from one neuron to another. One of the most important of these messengers is glutamate, the brain’s primary excitatory neurotransmitter. To keep neural circuits functioning properly, glutamate signaling must be continually adjusted as conditions change.
That balancing act is controlled in part by molecules known as group III metabotropic glutamate receptors, or mGluRs. These receptors act as regulators, helping ensure that communication between neurons remains within a healthy operating range.
Researchers know that mGluRs interact with proteins known as ELFNs, which help organize and regulate synaptic connection by forming the bridge that spans the neurons that release glutamate and the neurons that receive it. What remained unknown was exactly how those proteins are physically connected to form this bridge and influence one another.
The new study answers that question.
Using cryo-electron microscopy, the research team resolved atomic structure of the ELFN-mGluR complex, revealing precisely how the proteins interact.
How ELFN Proteins and Glutamate Receptors Work Together
The structural images revealed more than just a molecular handshake.
Researchers identified a previously unknown binding pocket on the receptor where ELFN proteins attach. That interaction influences how the receptor behaves, effectively giving scientists their first detailed look at one of the mechanisms the brain uses to adjust signaling strength.
The team also discovered evidence of a feedback system. When the receptor becomes activated, its interaction with ELFN proteins actually grows stronger. This finding suggests a built-in mechanism that may help synapses continually fine-tune communication and regulate signaling strength.
The findings move the field beyond simply knowing that ELFN proteins and mGlu receptors interact. Scientists can now explain how the interaction occurs and how it influences brain signaling at a structural level.
What is brain homeostasis?
Brain homeostasis is the process that keeps neural signals within a useful operating range: strong enough to be detected but not so strong that they overwhelm the system.
Insights Into Neurological Disease
The discovery may have important implications for understanding disease.
Disruptions in communication between neurons have been linked to a variety of brain disorders. In humans, mutations in both mGluR and ELFN genes in particular cause devastating neurodevelopmental condition manifesting in epilepsy, movement problems and developmental delays. The researchers found evidence that impaired ELFN-mGluR interactions represent a recurring mechanism in these disorders and that the newly mapped structures help explain how disease-associated mutations interfere with normal receptor regulation and brain homeostasis.
That knowledge could eventually give researchers a new way to intervene.
Rather than targeting the receptor’s traditional neurotransmitter-binding site, the newly identified regulatory interface could provide a potential target for future therapeutic discovery efforts. The structural map provides a foundation for exploring those possibilities.
From Structure to Therapy
While the findings create new opportunities for drug discovery, Dr. Martemyanov emphasizes that the work currently remains firmly in the realm of basic science. The next challenge is identifying molecules that can selectively influence the newly characterized protein complex. Researchers may be able to screen compounds against the structure or use computational approaches to design molecules that modify its activity.
“Knowing the structure allows us to, in a computational way, find those molecules,” Dr. Martemyanov said. “That would be the next step.”
Bringing any resulting therapy to patients would require years of additional research and testing. But the study provides the detailed molecular roadmap scientists need to continue the inquiry.
For Dr. Martemyanov and his collaborators, the discovery provides a framework for exploring what happens when those communication systems fail and how researchers might someday restore their balance.
More from the Miller School of Medicine
After their daughter was diagnosed with GNAO1, a rare neurological disorder, the Bell family helped build a global research community advancing scientific discoveries and hope for future treatments.
A University of Miami scientist discovers a novel brain receptor and nanobody therapy that could transform treatment for resistant depression.
The new chair says “breakthroughs are all about the people in my lab and dozens of contributors and collaborations across institutions.”
Tags: academic medicine, Department of Physiology & Biophysics, Dr. Henri Ford, Dr. Kirill Martemyanov, neuroscience